182 related articles for article (PubMed ID: 24038078)
1. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
Shishido SN; Delahaye A; Beck A; Nguyen TA
Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
[TBL] [Abstract][Full Text] [Related]
2. Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells.
Shishido SN; Nguyen TA
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840298
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model.
Shishido SN; Prasain K; Beck A; Nguyen TD; Hua DH; Nguyen TA
PLoS One; 2013; 8(6):e67174. PubMed ID: 23776708
[TBL] [Abstract][Full Text] [Related]
4. The effect of the PQ1 anti-breast cancer agent on normal tissues.
Ding Y; Prasain K; Nguyen TD; Hua DH; Nguyen TA
Anticancer Drugs; 2012 Oct; 23(9):897-905. PubMed ID: 22569107
[TBL] [Abstract][Full Text] [Related]
5. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
[TBL] [Abstract][Full Text] [Related]
6. Increase of gap junction activities in SW480 human colorectal cancer cells.
Bigelow K; Nguyen TA
BMC Cancer; 2014 Jul; 14():502. PubMed ID: 25008544
[TBL] [Abstract][Full Text] [Related]
7. [Quinoline derivative PQ1 combined with cisplatin promotes the proliferation and gap junction communication of prostate cancer PC3 cells].
Lin YZ; Xu N; Li XD; Xue XY; Cai H; Wei Y; Zheng QS
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):116-21. PubMed ID: 26939394
[TBL] [Abstract][Full Text] [Related]
8. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
Gakhar G; Hua DH; Nguyen TA
Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
[TBL] [Abstract][Full Text] [Related]
9. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
10. The effect of antineoplastic drugs in a male spontaneous mammary tumor model.
Shishido SN; Faulkner EB; Beck A; Nguyen TA
PLoS One; 2014; 8(6):e64866. PubMed ID: 23755153
[TBL] [Abstract][Full Text] [Related]
11. Gap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growth.
Shishido SN; Nguyen TA
PLoS One; 2012; 7(9):e44963. PubMed ID: 23028705
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities.
Lam JB; Chow KH; Xu A; Lam KS; Liu J; Wong NS; Moon RT; Shepherd PR; Cooper GJ; Wang Y
PLoS One; 2009; 4(3):e4968. PubMed ID: 19319191
[TBL] [Abstract][Full Text] [Related]
13. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro.
Perchellet EM; Crow KR; Gakhar G; Nguyen TA; Shi A; Hua DH; Perchellet JP
Int J Oncol; 2010 Mar; 36(3):673-88. PubMed ID: 20126988
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric expression of connexins between luminal epithelial- and myoepithelial- cells is essential for contractile function of the mammary gland.
Mroue R; Inman J; Mott J; Budunova I; Bissell MJ
Dev Biol; 2015 Mar; 399(1):15-26. PubMed ID: 25500615
[TBL] [Abstract][Full Text] [Related]
16. Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors.
Callahan R; Mudunur U; Bargo S; Raafat A; McCurdy D; Boulanger C; Lowther W; Stephens R; Luke BT; Stewart C; Wu X; Munroe D; Smith GH
Oncotarget; 2012 Nov; 3(11):1320-34. PubMed ID: 23131872
[TBL] [Abstract][Full Text] [Related]
17. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium.
Elzarrad MK; Haroon A; Willecke K; Dobrowolski R; Gillespie MN; Al-Mehdi AB
BMC Med; 2008 Jul; 6():20. PubMed ID: 18647409
[TBL] [Abstract][Full Text] [Related]
18. Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland.
Kańczuga-Koda L; Sulkowska M; Koda M; Reszeć J; Famulski W; Baltaziak M; Sulkowski S
Folia Morphol (Warsz); 2003 Nov; 62(4):439-42. PubMed ID: 14655136
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
20. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
